Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

When Does Hospital Noise Become a Health Alarm for Doctors?

Persistent hospital noise can increase stress, disrupt communication, and contribute to alarm desensitization, raising concerns about clinician well-being and patient safety.

Barrett Esophagus May Strike Decades Before Official Diagnosis

Professor Kit Curtius and graduate student Samuel Reynolds discuss their research on Barrett esophagus onset age, presented at DDW 2026.

Immune-Mediated Disease in Pregnancy Shapes Care Choices

Conflicting recommendations and limited evidence leave clinicians weighing disease control against medication risks across pregnancy, delivery, and breastfeeding.

EWG Scores vs Real Risk: How to Counsel Your Patients

Patients are skipping sunscreen, citing EWG’s low sunscreen approval rate. Here’s what EWG’s 20% figure means, and why DIY substitutes are harmful.

Doula Care Often Out of Reach for Mothers

Virginia Medicaid covers doula care, but low pay and complicated paperwork are making it harder for moms on Medicaid to find doulas who will accept their insurance.

Substance Use Disorders Decline but Treatment Gap Persists

Substance use and related disorders declined among teens and young adults, but millions of Americans with addiction still go untreated, new national survey data show.

Todays Updates

Enzalutamide vs Abiraterone: Which is Better for mCSPC?

Researchers compare enzalutamide vs abiraterone in the metastatic castration-sensitive prostate cancer setting.

Inconclusive BRCA Results Linked to Higher BC Risk

A new study assesses breast and ovarian cancer risk in women who carry a BRCA variant of uncertain significance or have a noninformative negative result.

Todays Updates

Enzalutamide vs Abiraterone: Which is Better for mCSPC?

Researchers compare enzalutamide vs abiraterone in the metastatic castration-sensitive prostate cancer setting.

Inconclusive BRCA Results Linked to Higher BC Risk

A new study assesses breast and ovarian cancer risk in women who carry a BRCA variant of uncertain significance or have a noninformative negative result.

Latest News

Persistent hospital noise can increase stress, disrupt communication, and contribute to alarm desensitization, raising concerns about clinician well-being and patient safety.

Professor Kit Curtius and graduate student Samuel Reynolds discuss their research on Barrett esophagus onset age, presented at DDW 2026.

Conflicting recommendations and limited evidence leave clinicians weighing disease control against medication risks across pregnancy, delivery, and breastfeeding.

Patients are skipping sunscreen, citing EWG’s low sunscreen approval rate. Here’s what EWG’s 20% figure means, and why DIY substitutes are harmful.

Virginia Medicaid covers doula care, but low pay and complicated paperwork are making it harder for moms on Medicaid to find doulas who will accept their insurance.

Substance use and related disorders declined among teens and young adults, but millions of Americans with addiction still go untreated, new national survey data show.

News All Time

Ultra-Processed Foods: What Are They and Why Do We Eat Them

Dr Anne Peters discusses tips for how to reduce ultra-processed food consumption with patients.

A Simpler Way to Use Estrogen Cream to Stop Repeat UTIs

For women past menopause, rubbing estrogen cream around the urinary opening may prevent repeat UTIs just as well as inserting it into the vagina with an applicator, with less itch.

Rome V Updates Diagnosis of Gut-Brain Axis Disorders

The updated Rome V criteria broaden IBS diagnosis and emphasize multidisciplinary care, including diet and psychological support, in chronic digestive disorders.

Top US Neurology and Neurosurgery Hospitals Ranked

NYU Langone Hospitals in New York City remains the best US hospital for neurology care, says the annual US News & World Report annual ranking of best hospitals for neurology and neurosurgery.

Prenatal Antidepressants Lower Postpartum Depression Risk

Continuing antidepressant medications during pregnancy is associated with lower postpartum depression risk in women with a history of depression.

NICE Expands First-Line Options for Two Blood Cancers

NICE has recommended acalabrutinib combinations for untreated MCL and CLL, including an all-oral option for some patients.

Incidence of Pediatric MS on the Rise in Netherlands

A Dutch study reveals a continuing rise in pediatric-onset multiple sclerosis, with incidence patterns during the COVID pandemic suggesting viral exposure may influence disease onset.

FDA Okays First-in-Class Narcolepsy Drug Oveporexton

Oveporexton (Orzeyful) is the first drug to target the underlying biological cause of narcolepsy type 1 by directly restoring orexin signaling.

Benralizumab Cuts Mucus Burden in Severe Eosinophilic Asthma

Treatment with benralizumab significantly reduces airway mucus burden and improves lung function by 13 weeks in patients with severe eosinophilic asthma.

Is Breast Really Best?

With the launch of Operation Stork Speed, the debate you thought was settled is heating up again. Dr Chris Labos reviews the evidence to answer the question: Is breast really best?

Stop ‘Nexting’ Patients and Start Mind Wandering Instead

Nexting is driven by schedule stress, but genuine mind wandering is a cognitive asset. Here’s how to tell the difference and stay present with patients.

Stem Cell Transplant Boosts Survival in Primary CNS Lymphoma

Among patients with primary CNS lymphoma who respond to induction therapy, high-dose chemotherapy with stem cell transplant improves survival compared with nonmyeloablative chemotherapy.

FDA Neurology Roundup: July 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Does ERBB2-Low Predict Poor Survival in Gastric Cancer?

Baseline clinical characteristics, rather than ERBB2 status, appeared to explain the survival differences observed between patients with ERBB2-low and ERBB2-null advanced gastric cancer.

Otitis Media Consults, Antibiotic Rx Rebound Post-Pandemic

Childhood otitis media consultation rates and consultations with antibiotic prescribing, which fell sharply during the COVID pandemic, have recovered post-pandemic in the UK and Netherlands.

NICE Criteria Miss 95% of Under-50s at Breast Cancer Risk

Full multifactorial assessment flagged 34.8% of women who developed breast cancer within a decade, against 4.4% under current NICE criteria.

Recommended News For You

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

How wildfires pose challenges to cancer care

Cancer screening rates down among American adults

Many women undergo annual mammography, despite biennial screening recommendations

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Recommended Articles For You

Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances 

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management 

Essential Updates in Hematology in Daily Practice 

Erythropoiesis Modulation in Chronic Anemia Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

2.

When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.

3.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

4.

An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.

5.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

1.

Precision Medicine in Modern Cancer Therapy

2.

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency

3.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

4.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

5.

The Genetics of Bernard Soulier Syndrome: What We Know so Far

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

4.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

5.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot